Authorization

Stock Alert: Marinus Pharmaceuticals Down 14%

(RTTNews) - Shares of Marinus Pharmaceuticals Inc. (MRNS) are currently losing 14% Friday morning. The company announced a mixed shelf offering of up to $250 million.

MRNS is currently trading at $2.0581, down $0.3419 or 14.2458%, on the Nasdaq.

In an SEC filing, Marinus Pharmaceuticals announced its plans to offer indeterminate number of common stock, preferred stock, debt securities and warrants from time to time, which together shall have an aggregate initial offering price not to exceed $250 million.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2020    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
24252627282930
31